Determine the optimal use of the superconductive quantum interference device (squid)/mri in low-field nmr. The technical advantages are a simpler magnet, a convenient, low cost magnet system for use in interventional procedures.
The construction of hybridomas producing monoclonal antibodies for new, more specific diagnostic kits for the detection of colon cancer and some air allergens.
A eureka consortium of scientists from research institutions and 8 leading plant breeding/biotechnology companies will apply innovative molecular techniques to solve urgent quality problems in the most important european cereals.
The aim is to obtain scientific and technological knowledge to develop a generic sterilisation and operation cassette for endoscopic instruments. Research targets: materials, configurations, construction, cleaning tubes, etc.
For some patients, voice production after laryngectomy is impossible.For others voice quality is unpredictable or poor to enable high-quality voice production for those patients, a voice-producing shunt prosthesis will be developed.
Method and equipment for heart tissue viability control during heart surgery operations will be developed using time-resolved, laser-induced fluorescence techniques, electrical activity mapping and thermovision.
The structural knowledge of the mutated androgen receptor ligand binding domain and its complexes with agonists and antagonists should shed light on controlling proliferation of prostate cancer cells, thus facilitating drug design.
Development of new monoclonal antibodies against signal transducer and transcription activator "stati" protein and its endogenous inhibitor "socs3" protein. Construction of kit for detection of hla-g antigens.
Development of algorithms for the evaluation of ischemic stroke volume from images of human brain computed tomography slices. This will be implemented in a computer aided medical diagnostic tool that can be used on personal computers.
Research on innovative hrs-pharma tech. For drug development, based on rapid high resolution screening (hrs) of mixtures with thousands of compounds, resulting in more and higher quality drug candidates and allowing research into 'awkward' pharmaceutical targets.